Acute kidney injury and multivessel percutaneous coronary interventions in chronic renal disease: the AMICI study.


Journal

Minerva cardiology and angiology
ISSN: 2724-5772
Titre abrégé: Minerva Cardiol Angiol
Pays: Italy
ID NLM: 101776555

Informations de publication

Date de publication:
10 2021
Historique:
pubmed: 5 11 2020
medline: 19 11 2021
entrez: 4 11 2020
Statut: ppublish

Résumé

Patients with chronic kidney disease (CKD) often have multivessel coronary artery disease and the risk of acute kidney injury (AKI) after percutaneous coronary interventions (PCI) is high. The aim of this study was to evaluate the risk of AKI in patients with CKD who underwent single vessel PCI versus multivessel PCI. We retrospectively screened all PCI performed from January 2011 to December 2017 and we included all the procedures performed in patients with a baseline glomerular filtration rate <60 mL/min/1.73 m From a total of 4517 PCI screened, 848 PCI were included, 530 in the mono group and 318 in the multi group. The global rate of AKI was around 15% without significant differences between the mono and the multi group (15.5% in the mono and 14.8% in the multi group, P=0.786). In the multi group, the risk of AKI was significantly higher in the Single session sub-group (21.4%) compared to the staged sub-group (11.2%, P=0.014). In patients with CKD, the risk of AKI did not differ in patients who underwent single vessel versus multivessel PCI, but multivessel PCI should be performed in multiple staged procedures rather than in a single session.

Sections du résumé

BACKGROUND
Patients with chronic kidney disease (CKD) often have multivessel coronary artery disease and the risk of acute kidney injury (AKI) after percutaneous coronary interventions (PCI) is high. The aim of this study was to evaluate the risk of AKI in patients with CKD who underwent single vessel PCI versus multivessel PCI.
METHODS
We retrospectively screened all PCI performed from January 2011 to December 2017 and we included all the procedures performed in patients with a baseline glomerular filtration rate <60 mL/min/1.73 m
RESULTS
From a total of 4517 PCI screened, 848 PCI were included, 530 in the mono group and 318 in the multi group. The global rate of AKI was around 15% without significant differences between the mono and the multi group (15.5% in the mono and 14.8% in the multi group, P=0.786). In the multi group, the risk of AKI was significantly higher in the Single session sub-group (21.4%) compared to the staged sub-group (11.2%, P=0.014).
CONCLUSIONS
In patients with CKD, the risk of AKI did not differ in patients who underwent single vessel versus multivessel PCI, but multivessel PCI should be performed in multiple staged procedures rather than in a single session.

Identifiants

pubmed: 33146482
pii: S0026-4725.20.05408-0
doi: 10.23736/S2724-5683.20.05408-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

491-498

Auteurs

Alessandro Sciahbasi (A)

Department of Interventional Cardiology, Sandro Pertini Hospital, Rome, Italy - asciahbasi@gmail.com.

Andrea Cuono (A)

Department of Interventional Cardiology, Sandro Pertini Hospital, Rome, Italy.

Alberto Marrangoni (A)

Department of Interventional Cardiology, Santo Spirito Hospital, Pescara, Italy.

Francesco Perone (F)

Department of Cardiology, University of L'Aquila, L'Aquila, Italy.

Giacomo Nucci (G)

Department of Cardiology, University of L'Aquila, L'Aquila, Italy.

Vanessa Porretta (V)

Department of Cardiology, University of L'Aquila, L'Aquila, Italy.

Nunzia Borrelli (N)

Department of Cardiology, University of L'Aquila, L'Aquila, Italy.

Silvio Fedele (S)

Department of Interventional Cardiology, Sandro Pertini Hospital, Rome, Italy.

Silvio Romano (S)

Department of Cardiology, University of L'Aquila, L'Aquila, Italy.

Massimo DI Marco (M)

Department of Interventional Cardiology, Santo Spirito Hospital, Pescara, Italy.

Maria Penco (M)

Department of Cardiology, University of L'Aquila, L'Aquila, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH